Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Xbrane Biopharma AB

Closing information (x1000 EUR)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 5,178 Less Arrow 0 Equal arrow 0
Financial expenses 206 More Arrow 258 Less Arrow 77
Earnings before taxes -15,143 Less Arrow -17,916 Less Arrow -22,518
EBITDA -14,268 Less Arrow -16,463
Total assets 62,050 More Arrow 67,315 Less Arrow 46,203
Current assets 46,146 More Arrow 54,856 Less Arrow 37,308
Current liabilities 21,258 More Arrow 21,479 Less Arrow 18,829
Equity capital 38,181 More Arrow 42,216 Less Arrow 25,675
- share capital 554 Less Arrow 549 Less Arrow 344
Employees (average) 68 Less Arrow 50 Less Arrow 39

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 61.5% More Arrow 62.7% Less Arrow 55.6%
Turnover per employee 76 Less Arrow 0 Equal arrow 0
Profit as a percentage of turnover -292.4%
Return on assets (ROA) -24.1% Less Arrow -26.2% Less Arrow -48.6%
Current ratio 217.1% More Arrow 255.4% Less Arrow 198.1%
Return on equity (ROE) -39.7% Less Arrow -42.4% Less Arrow -87.7%
Change turnover 5,178 Less Arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 18 Less Arrow 11 Less Arrow 3
Chg. No. of employees % 36% Less Arrow 28% Less Arrow 8%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.